News | February 17, 2023
Biocon Q3 FY23 revenue up 36%
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The CRL did not identify any outstanding scientific issues with the product.
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
The product will be launched by NATCO's commercial partner Viatris.
Subscribe To Our Newsletter & Stay Updated
